Granza Bio Secures $7.14M Seed Funding for Novel Therapeutic Delivery Platform
| | | |

Granza Bio Secures $7.14M Seed Funding for Novel Therapeutic Delivery Platform

Granza Bio, a biotechnology company founded in 2024 by a team of cancer and immunology researchers at the University of Oxford, has announced the successful close of its oversubscribed $7.14M Seed funding round. The company is focused on developing a novel delivery platform that leverages the discovery of the immune systems attack particles to combat…

Thermo Fisher Scientific Completes Acquisition of Olink Holding AB (publ)
| | |

Thermo Fisher Scientific Completes Acquisition of Olink Holding AB (publ)

Thermo Fisher Scientific Inc. has completed its acquisition of Olink Holding AB (publ), a leading provider of nextgeneration proteomics solutions. The transaction valued Olink at approximately $3.1 billion. Thermo Fisher intends to leverage Olinks transformative solutions for proteomics to accelerate scientific breakthroughs in protein research.

Sanborn Map Company Acquires VeriDaaS Assets in Strategic Move
| |

Sanborn Map Company Acquires VeriDaaS Assets in Strategic Move

The Sanborn Map Company Inc. has recently acquired the assets of VeriDaaS, a technology company specializing in Geiger mode lidar. The acquisition aligns with Sanborns strategic vision to continue growth and provide the latest technology to customers. Sanborn plans to integrate VeriDaaS assets and solutions into the Mapping Division to enhance their ability to deliver…

MedPharm and Tergus Pharma Merger Creates Leading CDMO in Topical and Transdermal Pharmaceuticals
| | | |

MedPharm and Tergus Pharma Merger Creates Leading CDMO in Topical and Transdermal Pharmaceuticals

MedPharm, a global topical and transdermal Contract Development and Manufacturing Organization (CDMO), has announced a merger with Tergus Pharma. This strategic partnership establishes MedPharm as a leading endtoend CDMO with comprehensive scientific, clinical trial manufacturing, and commercial production capabilities. The merged organization will operate under the MedPharm name, with Tergus Pharma CEO Michael Kane appointed…

Natcap Secures $10 Million in Series A Funding Round
| | |

Natcap Secures $10 Million in Series A Funding Round

Natural Capital Research Limited (Natcap) has secured $10 million in an oversubscribed Series A funding round to scale its pioneering nature tech product. The funding will be used to accelerate Natcaps rapid growth in supporting organizations to understand their naturerelated risks and opportunities. The companys focus is to scale the delivery of highquality nature data…

Harvest Integrated Research Organization (HiRO) Acquires DeltaMed Solutions to Expand Global Presence
| |

Harvest Integrated Research Organization (HiRO) Acquires DeltaMed Solutions to Expand Global Presence

Harvest Integrated Research Organization (HiRO), a fullservice, boutique global CRO, announced the successful acquisition of DeltaMed Solutions, an emerging CRO with a strong foothold in the US. The acquisition, advised by Evercore as financial advisor, marks HiROs third CRO acquisition since its establishment in 2020. DeltaMed Solutions, headquartered in New Jersey, brings a team of…

Freeflow Ventures Raises $50M to Invest in ScienceDriven Solutions to Human and Planetary Health Challenges
| | |

Freeflow Ventures Raises $50M to Invest in ScienceDriven Solutions to Human and Planetary Health Challenges

Freeflow Ventures, a venture capital firm focused on investing in sciencedriven solutions to human and planetary health challenges, has raised $50 million in new funds. The funding includes $35 million for Fund Two and $15 million for the Opportunity Fund. With previous funds, Freeflow now manages $90 million in assets. The firm has a track…

Susan G. Komen® Awards $10.05 Million in Research Grants for Breast Cancer Treatment Advancements
| | |

Susan G. Komen® Awards $10.05 Million in Research Grants for Breast Cancer Treatment Advancements

Susan G. Komen®, the leading breast cancer organization, has allocated $10.05 million in research grants to support advancements in breast cancer treatment. The grants aim to improve patient lives through better treatments for metastatic disease and precision medicine. The funding will further cuttingedge breast cancer research at prestigious institutions worldwide, supporting researchers early in their…

Foray Bioscience Raises $3 Million in Seed Funding
| | |

Foray Bioscience Raises $3 Million in Seed Funding

Foray Bioscience, a startup specializing in plantless plant products, has secured $3 million in seed funding. The company will utilize the funds to expand its predictive plant cell culture platform, launch product development engagements with partners, and grow its Bostonbased team. The funding round was led by ReGen Ventures, with additional investors including The Engine…

Windyty, S.E. Acquires Majority Stake in meteoblue, A.G. to Strengthen Global Weather Forecasting Leadership
| | |

Windyty, S.E. Acquires Majority Stake in meteoblue, A.G. to Strengthen Global Weather Forecasting Leadership

Windyty, S.E., the operator of Windy.com, a leading global weather service, has announced the acquisition of a majority stake in meteoblue, A.G., a Baselbased company known for its highaccuracy weather forecasting services. The partnership aims to enhance global reach, innovation potential, and visualization capabilities in the weather forecasting industry. The funding will be used to…